Incidence and management of hypotension in spinal anaesthesia in urological pelvic surgery
DOI:
https://doi.org/10.60988/p.v37i2S.210Keywords:
hypotension; spinal anaesthesia; urological surgery; ephedrine; intravenous administrationAbstract
The management of hypotension in specific clinical contexts frequently involves the administration of ephedrine; a vasopressor with demonstrated efficacy across multiple scenarios: spinal anaesthesia for uro-pelvic surgery, caesarean section, renal transplantation, and select cases of autonomic dysfunction. Recent evidence suggests that ephedrine use may delay the onset of hypotension. This prospective study has evaluated the incidence and management of hypotension in 80 adult patients (aged 17–45 years) undergoing urological pelvic surgery under spinal anaesthesia. Participants were recruited from the Hilla Teaching Hospital and the Al-Imam Al-Sadeq Teaching Hospital (Iraq) between June 2023 and December 2024, and were randomly assigned to receive either intravenous fluids alone or in combination with ephedrine. Systemic blood pressure was monitored at four time points: preoperatively, following intervention, after anaesthesia induction, and postoperatively. Compared to fluid administration alone, the ephedrine-treated group exhibited significant changes in both systolic and diastolic blood pressure values (p<0.05). These findings suggest that ephedrine enhances haemodynamic stability during spinal anaesthesia and may play a clinically significant role in the intraoperative management of hypotension.
References
1. Bhat S.G.K., Mukund M., Bhat G., Hegde H., B S. Preoperative bedside ultrasound-guided inferior venacava collapsibility index as a guide to predict hypotension following spinal anesthesia in patients scheduled for elective surgery. Reg. Anesth. Pain Med. 47, A276, 2022. DOI: 10.1136/rapm-2022-ESRA.482
2. Fayadh N.A.H., Jaafar Khaleel Al-Anbari A., Al-Alosi B.M.H. Brachial artery injury in Al-Emamain Al-Kadhymain Medical City, Baghdad, Iraq: a single-center clinical experience. Interv. Akut. Kardiol. 22(3), 109–113, 2023. DOI: 10.36290/kar.2022.033
3. Hofhuizen C., Lemson J., Snoeck M., Scheffer G.J. Spinal anesthesia-induced hypotension is caused by a decrease in stroke volume in elderly patients. Local Reg. Anesth. 12, 19–26, 2019. DOI: 10.2147/LRA.S193925
4. Kim H., Lee S., Koh W.U., Cho J., Park S.W., Kim K.S., et al. Norepinephrine prevents hypotension in older patients under spinal anesthesia with intravenous propofol sedation: a randomized controlled trial. Sci. Rep. 13(1), 21009, 2023. DOI: 10.1038/s41598-023-48178-2
5. Tatikonda C.M., Rajappa G.C., Rath P., Abbas M., Madhapura V.S., Gopal N.V. Effect of intravenous ondansetron on spinal anesthesia-induced hypotension and bradycardia: a randomized controlled double-blinded study. Anesth. Essays Res. 13(2), 340–346, 2019. DOI: 10.4103/aer.AER_22_19
6. Park H.S., Choi W.J. Use of vasopressors to manage spinal anesthesia-induced hypotension during cesarean delivery. Anesth. Pain Med. (Seoul) 19(2), 85–93, 2024. DOI: 10.17085/apm.24037
7. Uemura Y., Kinoshita M., Sakai Y., Tanaka K. Hemodynamic impact of ephedrine on hypotension during general anesthesia: a prospective cohort study on middle-aged and older patients. BMC Anesthesiol. 23(1), 283, 2023. DOI: 10.1186/s12871-023-02244-4
8. Tchaou B.A., Massaoulé S.B., Marjolaine Oriane D.B., Yapo B. Management of arterial hypotension induced by spinal anesthesia during cesarean section at the Parakou University Hospital in Benin in 2020: ephedrine versus noradrenaline. Open J. Anesthesiol. 12, 351–367, 2022. DOI: 10.4236/ojanes.2022.1212031
9. Yoo H.J., Yoon H.Y., Yee J., Gwak H.S. Effects of ephedrine-containing products on weight loss and lipid profiles: a systematic review and meta-analysis of randomized controlled trials. Pharmaceuticals (Basel) 14(11), 1198, 2021. DOI: 10.3390/ph14111198
10. Mandal P., Singh A., Sharma K., Jain P., Manisha, Chaudhary M., et al. Ephedrine and pseudoephedrine: a comprehensive review of their pharmacology and clinical applications. J. Chem. Health Risks 14(1), 1447–1455, 2024.
